The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
about
Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung CancerMonosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradationSurgery for localised small cell lung cancerMaintenance therapy for advanced non-small cell lung cancer (NSCLC)Interventions for smoking cessation in people diagnosed with lung cancerInterventions for smoking cessation in people diagnosed with lung cancerThird-line systemic treatment for non-small cell lung cancerLung cancer staging: clinical and radiologic perspectivesProfile of farletuzumab and its potential in the treatment of solid tumorsImmunotherapy for lung cancerNavigational Bronchoscopy for Early Lung Cancer: A Road to TherapyPrognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-AnalysisPhotodynamic Therapy in Non-Gastrointestinal Thoracic MalignanciesEGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancerRobotic-Assisted Videothoracoscopic Surgery of the LungComputer modeling of lung cancer diagnosis-to-treatment processEarly detection of lung cancer: Low-dose computed tomography screening in ChinaTreatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?Staging lymph node metastases from lung cancer in the mediastinumTowards optimal pathologic staging of resectable non-small cell lung cancerFarletuzumab in lung cancer2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerTherapeutic strategy for postoperative recurrence in patients with non-small cell lung cancerAdvanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendationsNew TNM classification: achievements and hurdlesManagement strategy of solitary pulmonary nodulesPrimary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patientsLung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.The role of surgical intervention in lung cancer with carcinomatous pleuritisEmerging therapeutic agents for lung cancerChina Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survivalAKAP4 is a circulating biomarker for non-small cell lung cancerInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaThe expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohortsLung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literature
P2860
Q21198841-F93C7F6A-6A74-442A-A468-17D780F6F2D7Q22241671-4807B6BB-C6E5-4191-AB97-684BAB8F4F71Q23923209-42AAE97E-9E4C-4AB0-B735-2F84A6B42545Q24186777-F4E8F741-EA5B-4297-AE13-D5654A56A7C2Q24186793-B850FB3D-B2B8-4856-9F25-F6FD093633E5Q24187218-7642F147-DF99-4E31-8413-C0C9FBDAA9C5Q24187486-D5FBC67B-E9ED-4A6D-AC0B-C976CD780089Q24194090-15EB6F95-499A-47BD-BA3B-9E9E64CE83D7Q24600394-9E9744B8-1714-4DF9-ADDA-5BEBEAB3906CQ26750431-097D4065-7573-4C87-92D4-C096F411EF0EQ26751254-3B4C5745-BD42-4F97-B75D-DF63238836BDQ26753056-532A5F92-B667-4322-AE38-B90666C05C7DQ26771327-1BA2BAD3-567A-4E7F-849A-097AAE1B6BE7Q26775131-C3C83FF1-8636-4B92-A5D6-995E9BEBCDB5Q26778298-6D4FDEE0-EF15-4460-AB1F-41011E60C715Q26781856-23773906-1A6F-43ED-9E9D-2CC61F915C5AQ26782241-A2AD0892-35F1-46C7-96E4-AA2F948207B1Q26784079-B972063A-6CCB-445E-A9CD-181E9231E877Q26798223-4AC70579-B2B9-4724-8392-A2C804533A0FQ26853124-046803C2-CF98-47C6-85C7-1180A4B96235Q26863443-7A49C3E2-F91D-4985-983F-3E1BB1C738BAQ26991912-38507155-7082-4C7B-98A4-0854D074CB29Q26997008-E103FDE5-8224-4215-96C8-14A530726004Q27002509-EF1B64F4-A526-4CE5-848B-142E38F9FA32Q27011293-AC67E37C-6CC7-4A4E-A410-C78438101635Q27021203-2CDE25D9-0465-4F18-8CF5-97C3B915D54FQ27022737-312E1F7F-28B4-4D6D-8286-727A0824F1B0Q27022971-F75D8473-8F34-4C36-9865-537DDE97C873Q27852993-97828F26-8513-483C-BC01-B386796B323DQ27853282-F16D8C0F-8634-4F41-B8C6-2044130FB785Q28068169-BF03D0C0-AC3E-4C1E-98FF-9A14A10CB25EQ28070165-9A7EE22B-26C2-4141-8B23-709682684635Q28073920-B0B1C469-9787-4B2B-B0FE-CE6E37DB8DB6Q28083924-9E319087-3394-454D-8CB5-179D5F3C0485Q28116258-E75AEF54-076D-4136-B9E8-020D34DFECF5Q28236372-70C853B3-CCF5-444C-A050-DCA9ABF53054Q28264905-0214ED55-43FF-47B7-9879-3B275562158AQ28303718-8267AEC7-25D1-4880-A9A2-D07A60F85A71Q28383695-D42B440E-A827-4A3A-85E5-2FC677435E10Q28386127-30DB2CD0-E70B-4A1A-8134-5E8EA6B28035
P2860
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The IASLC Lung Cancer Staging ...... ification of malignant tumours
@en
The IASLC Lung Cancer Staging ...... e groupings in the forthcoming
@nl
type
label
The IASLC Lung Cancer Staging ...... ification of malignant tumours
@en
The IASLC Lung Cancer Staging ...... e groupings in the forthcoming
@nl
prefLabel
The IASLC Lung Cancer Staging ...... ification of malignant tumours
@en
The IASLC Lung Cancer Staging ...... e groupings in the forthcoming
@nl
P2093
P1476
The IASLC Lung Cancer Staging ...... ification of malignant tumours
@en
P2093
Goldstraw P
Postmus PE
Rami-Porta R
P304
P356
10.1097/JTO.0B013E31812F3C1A
P407
P577
2007-08-01T00:00:00Z